Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Basic Res Cardiol. 2011 Jul 22;106(6):1367–1377. doi: 10.1007/s00395-011-0208-6

Fig. 6.

Fig. 6

Relationship between size of region at risk and size of MI 1 year after rAAV/HO-1 gene therapy. Graphs show individual values and regression lines obtained by linear regression analysis for the various groups. Left sham and late PC groups. Right rAAV/LacZ and rAAV/HO-1 groups. In all groups, infarct size was positively and linearly related to risk region size. However, the slopes of the regression lines were smaller in the late PC and rAAV/HO-1 groups as compared to the sham and rAAV/LacZ control groups, respectively, demonstrating an attenuated infarct size response to myocardial injury in both of the late PC (24 h) and rAAV/HO-1 gene therapy (1 year)